USA: Engineering Contract Fluor Places Final Beam for Bayer's New Cell Culture Technology Center in California
Fluor Corporation and Bayer placed the final steel beam for Bayer’s new cell culture technology center being constructed in Berkeley, California.
Irving/USA — At its new Single Use Technology (SUT), biopharmaceutical manufacturing facility in Berkeley, Bayer will produce future therapies for oncology and other diseases. It is scheduled to be ready for first clinical production in late 2021.
Fluor is providing engineering, procurement, construction management, commissioning and qualification services for the facility. In 2018, the company engaged in the conceptual study and front-end engineering design for the project. Bayer chose the company's concept because of the innovative plant layout and modularized construction solution that allowed the facility to be designed and built with capital efficiency and schedule optimization.
Bayer selected GE Healthcare to provide its Flex Factory SUT platform which is being incorporated into the project through a collaborative subcontract to Fluor. GE Healthcare is supplying all major unit operations, systems and ancillary equipment and components. The engineering company's scope also includes utility process integration for the entire facility.